Connect with us

Business

North America's second bitcoin ETF launches in Canada today – Yahoo Canada Finance

Published

 on


GlobeNewswire

VerifyMe Announces Exercise by Maxim of 100,000 Shares From Over-allotment Option

Exercise Price of $5.30 – Balance of Option is 147,000 sharesROCHESTER, N.Y., Feb. 19, 2021 (GLOBE NEWSWIRE) — VerifyMe, Inc. (NASDAQ: VRME) (“VerifyMe,” or the “Company”), a technology solutions provider specializing in brand protection functions such as counterfeit prevention, authentication, serialization, track and trace features for labels, packaging and products, today announced the closing of the sale of an additional 100,000 shares of common stock, at a price to the public of $5.30 per share less underwriting discounts and commissions, pursuant to the partial exercise of the underwriters’ over-allotment option in connection with its previously announced offering of 1,650,000 shares of common stock of the Company. The Company expects to receive additional gross proceeds of $530,000, before deducting underwriting discounts and commissions and estimated offering expenses. The underwriters continue to have an over-allotment option to purchase 147,500 shares of the Company’s common stock. Maxim Group LLC acted as sole book-running manager for the offering. Joseph Gunnar & Co., LLC acted as co-manager for the offering. The shares of common stock were offered pursuant to a shelf registration statement on Form S-3 (File No. 333-251837) previously filed and declared effective by the Securities and Exchange Commission (SEC). A prospectus supplement was filed with the SEC and forms a part of the effective registration statement. Copies of the prospectus supplement and accompanying prospectus relating to the public offering may be obtained, by contacting Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, or by telephone at (212) 895-3745. This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. About VerifyMe, Inc. VerifyMe, Inc. (NASDAQ: VRME), is a technology solutions provider specializing in brand protection functions such as counterfeit prevention, authentication, serialization, and track and trace features for labels, packaging and products. VerifyMe’s physical technology authenticates packaging, labels and documents with a suite of proprietary security inks and pigments, which work in conjunction with serialization and track and trace software known as VeriPAS™ that allows both consumers and brand inspectors to verify authenticity with their smartphones. VeriPAS™ is a serialization software system that brand owners access through a web portal to monitor, control and protect their products complete life cycle. To learn more, visit www.verifyme.com. Cautionary Note Regarding Forward-Looking Statements This release contains forward-looking statements regarding our financial condition, results of operations, business strategy and financial needs. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the impact of the COVID-19 pandemic, intellectual property litigation, the successful development of our sales and marketing capabilities, our ability to retain key management personnel, our ability to work with partners in selling our technologies to businesses, production difficulties, our inability to enter into contracts and arrangements with future partners, issues which may affect the reluctance of large companies to change their purchasing of products, acceptance of our technologies and the efficiency of our authenticators in the field. Further information on our risk factors is contained in our filings with the Securities and Exchange Commission (the “SEC”), including under the heading “Risk Factors” in the Annual Report on Form 10-K for the year ended December 31, 2019 and the Quarterly Report on Form 10-Q for the three months ended September 30, 2020. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. For Licensing or Other Information Contact:Company: VerifyMe, Inc.Email: IR@verifyme.comWebsite: http://www.verifyme.com Investors:ClearThinknyc@clearthink.capital

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Key COVID-19 numbers in the Ottawa area today – CBC.ca

Published

 on


  • Ottawa is reporting 55 new cases of COVID-19 on Sunday.
  • Another 25 cases recorded in western Quebec.

Today’s Ottawa update

Ottawa Public Health (OPH) recorded 55 new cases of COVID-19 on Sunday but zero deaths. 

Another 39 cases have been classified as resolved.

Ottawa and communities under the Eastern Ontario Health Unit (EOHU) are now in the orange alert level, with slightly more restrictive rules than the rest of eastern Ontario, which is green.

Ottawa’s medical officer of health is backing up what some key numbers and experts have suggested: that the capital is close to moving to the red zone if the spread of COVID-19 doesn’t slow.

Numbers to watch

33.8: The weekly incidence rate, a rolling seven-day total of new COVID-19 cases expressed per 100,000 residents. The red zone threshold is 40.

.98: The number of people infected by a single COVID-19 case, or R(t). Health officials consider the spread under control if it’s below one.

34: The number of outbreaks in Ottawa.

504: The number of known active COVID-19 cases in Ottawa. One month ago there were more than 1,200.

Across the region

In western Quebec, another 25 cases were reported on Sunday but no new deaths. 

Let’s block ads! (Why?)



Source link

Continue Reading

Business

LILLEY: Trudeau makes Canada 'vaccine pirate,' stealing from poor nations – Toronto Sun

Published

 on


Article content

Canada is being described as a “vaccine pirate” after the latest announcement of COVID vaccine approvals showed we will be getting our doses from a facility funded to provide vaccines for the developing world.

On Friday, Health Canada announced that they had approved two related but distinct products, the AstraZeneca vaccine developed in collaboration with Oxford University and COVISHIELD, a version of the AstraZeneca recipe manufactured by Serum Institute of India.

The problem is that Canada will be getting its doses, starting as early as Wednesday, from the Serum Institute, an organization funded to produce vaccine doses for low- and middle-income countries.

Like the announcement that the Trudeau government will take 1.9 million doses from COVAX, this makes it look like Canada is taking vaccines meant for poorer countries.

In a news release last June announcing the deal that would allow the SII to produce the AstraZeneca vaccine, the company specifically said it was “to supply 1 billion doses for low-and-middle-income countries” In September, a donation from the Bill and Melinda Gates Foundation allowed the program to expand by an extra 100 million doses.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

“This is vaccine manufacturing for the Global South, by the Global South, helping us to ensure no country is left behind when it comes to the race for a COVID-19 vaccine,” said Dr. Seth Berkley, CEO Gavi, the alliance to ensure poor countries have access to vaccines.

Now Canada has found its way to the front of that line.

Procurement Minister Anita Anand confirmed on Friday that of the 3.9 million doses of the AstraZeneca/COVISHIELD vaccines that we will see delivered before the end of June, 2 million will come from the Serum Institute and 1.9 million from COVAX.

The move has led one former Canadian health bureaucrat who now works internationally to accuse the Trudeau government of turning Canada into a “global vaccine pirate.” It’s a view held by many people paying attention to the details of our latest vaccine announcement.

We apologize, but this video has failed to load.

Amir Attaran, a professor with the School of Epidemiology and Public Health at the University of Ottawa, accused the Trudeau government of poaching these doses from developing countries.

“How many people in other lands will this kill? ‘Sunny ways’ it isn’t,” Attaran said on Twitter.

Dr. Srinivas Murthy, an infectious disease specialist with the B.C. Children’s Hospital, said that Canada was taking doses away from LMICs or low and middle-income countries.

“This is much more anger-inducing than the COVAX conversation weeks ago. The Serum Institute of India was funded by CEPI and GAVI to produce vaccines for LMICs. Canada, because of diplomacy and money, is skipping that line and taking doses meant for LMICs,” Dr. Murthy said.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

When the Trudeau government announced at the beginning of February that we would be taking vaccines from COVAX, the move was blasted by a broad range of organizations including Doctors Without Borders and Oxfam.

“Canada should not be taking the COVAX vaccine from poor nations to alleviate political pressures at home,” Oxfam said at the time.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Yet, that is exactly what Trudeau was doing in early February and it is what he is doing now. Canadians are upset at seeing Americans, Brits, Italians, Serbians and Barbadians vaccinated much fast than we are, and they are rightly blaming the federal government.

Even the record 643,000 doses received across the country last week is less than the Americans use before lunch each day.

Justin Trudeau campaigned on improving Canada’s reputation on the world stage, now we are taking vaccines meant for developing countries. It is nothing short of a national embarrassment.

The Trudeau government owes Canadians an explanation on his latest moves; let’s hope he faces the tough questions he should later this week.

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Experts advise Canadians to take whatever COVID-19 vaccine is offered – CBC News: The National

Published

 on


[unable to retrieve full-text content]

  1. Experts advise Canadians to take whatever COVID-19 vaccine is offered  CBC News: The National
  2. Coronavirus: What’s happening in Canada and around the world on Sunday  CBC.ca
  3. AstraZeneca approval opens door to some B.C. front-line workers getting earlier vaccine  Global News
  4. Europe must get its act together with Covid vaccine rollout  Telegraph.co.uk
  5. Keep up COVID-19 protocols as vaccines roll out, experts say  CBC News: The National
  6. View Full coverage on Google News



Source link

Continue Reading

Trending